U.S. patent application number 15/831673 was filed with the patent office on 2018-04-05 for medical device delivery.
The applicant listed for this patent is Covidien LP. Invention is credited to Richard S. Kusleika.
Application Number | 20180092765 15/831673 |
Document ID | / |
Family ID | 28039045 |
Filed Date | 2018-04-05 |
United States Patent
Application |
20180092765 |
Kind Code |
A1 |
Kusleika; Richard S. |
April 5, 2018 |
MEDICAL DEVICE DELIVERY
Abstract
A stent delivery assembly can include a stent, a tube, a shaft
slidably disposed within the tube, and an engagement member on the
shaft. The engagement member is operable via the shaft so as to
facilitate manipulation of the stent via the shaft. The engagement
member can engage the stent inner wall and cooperating with the
tube to grip the stent. The shaft is arranged within the tube with
a close tolerance between the shaft and the tube so as to provide
stability during retraction or advancement of the shaft.
Inventors: |
Kusleika; Richard S.;
(Excelsior, MN) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Covidien LP |
Mansfield |
MA |
US |
|
|
Family ID: |
28039045 |
Appl. No.: |
15/831673 |
Filed: |
December 5, 2017 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
14076448 |
Nov 11, 2013 |
9849014 |
|
|
15831673 |
|
|
|
|
13614035 |
Sep 13, 2012 |
8579958 |
|
|
14076448 |
|
|
|
|
12477613 |
Jun 3, 2009 |
8317850 |
|
|
13614035 |
|
|
|
|
11035671 |
Jan 14, 2005 |
|
|
|
12477613 |
|
|
|
|
10096628 |
Mar 12, 2002 |
6866679 |
|
|
11035671 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61F 2/82 20130101; A61F
2/95 20130101; A61F 2/966 20130101; A61F 2/962 20130101 |
International
Class: |
A61F 2/962 20060101
A61F002/962; A61F 2/966 20060101 A61F002/966; A61F 2/95 20060101
A61F002/95; A61F 2/82 20060101 A61F002/82 |
Claims
1. (canceled)
2. A medical device delivery assembly comprising: a catheter having
a distal region, a proximal region, and a lumen that extends from
the proximal region through the distal region; a delivery member
having a distal end and extending within the catheter lumen; and a
braided member having a first end, a second end, an intermediate
region disposed between the first end and the second end, and a
lumen extending from the first end to the second end, the first end
being (i) coupled to the delivery member distal end and (ii)
constrained by the delivery member distal end from radially
expanding beyond the delivery member distal end, the second end
being unconstrained by the delivery member distal end, wherein the
braided member is evertible between a first configuration and a
second configuration, wherein in the first configuration the second
end is positioned proximal to the first end, and wherein in the
second configuration the second end is positioned distal to the
first end.
3. The medical device delivery assembly of claim 1, wherein in the
first configuration, the first end is everted inwardly.
4. The medical device delivery assembly of claim 1, wherein in the
second configuration, the first end is non-everted.
5. The medical device delivery assembly of claim 1, wherein in the
first configuration the second end is positioned within the
catheter lumen.
6. The medical device delivery assembly of claim 1, wherein in the
first configuration the braided member is positioned against an
inner wall of the catheter.
7. The medical device delivery assembly of claim 1, wherein the
braided member is metallic.
8. The medical device delivery assembly of claim 1, wherein the
braided member comprises a stent.
9. The medical device delivery assembly of claim 1, wherein the
delivery member comprises a tube having a lumen.
10. The medical device delivery assembly of claim 9, wherein the
first end is received within the delivery member lumen.
11. The medical device delivery assembly of claim 1, wherein the
tubular member is configured to radially expand when radially
unrestrained from the delivery member.
12. The medical device delivery assembly of claim 1, wherein the
catheter is a microcatheter.
13. A medical device delivery assembly comprising: a delivery
member having a distal portion; and an elongate braided member
having a first portion and a second portion, the first portion
being (i) coupled to the delivery member distal portion and (ii)
constrained by the delivery member distal portion from radially
expanding beyond the delivery member distal portion, the second
portion being unconstrained by the delivery member distal portion,
wherein the braided member is evertible between a first
configuration and a second configuration, wherein in the first
configuration the first portion is everted into the second portion,
and wherein in the second configuration the first portion is in a
non-everted position and the second portion extends distally from
the first portion.
14. The medical device delivery assembly of claim 13, further
comprising a catheter defining a lumen, wherein the delivery member
extends through the catheter lumen.
15. The medical device delivery assembly of claim 14, wherein in
the first configuration the second portion extends within the
microcatheter lumen.
16. The medical device delivery assembly of claim 13, wherein in
the second configuration, the first portion is non-everted.
17. The medical device delivery assembly of claim 13, wherein the
braided member is metallic.
18. The medical device delivery assembly of claim 13, wherein the
braided member is tubular.
19. The medical device delivery assembly of claim 13, wherein the
delivery member comprises a tube having a lumen.
20. The medical device delivery assembly of claim 19, wherein the
first portion is received within the delivery member lumen.
21. The medical device delivery assembly of claim 13, wherein the
braided member is configured to radially expand when radially
unrestrained by the delivery member.
Description
[0001] This application is a continuation of U.S. application Ser.
No. 14/076,448, filed Nov. 11, 2013, which is a continuation of
U.S. application Ser. No. 13/614,035, filed Sep. 13, 2012, now U.S.
Pat. No. 8,579,958, which is a continuation of U.S. application
Ser. No. 12/477,613, filed Jun. 3, 2009, now U.S. Pat. No.
8,317,850, which is a divisional of U.S. application Ser. No.
11/035,671, filed Jan. 14, 2005, now abandoned, which is a
continuation of U.S. application Ser. No. 10/096,628, filed Mar.
12, 2002, now U.S. Pat. No. 6,866,679. The entire contents of each
of the foregoing applications and patent are incorporated herein by
reference in their entirety.
TECHNICAL FIELD
Field
[0002] The present inventions relates generally to medical devices.
More specifically, the present inventions relate to stents. The
stents may find particular use in intravascular procedures in
general, and in cardiovascular procedures in particular, as well as
other areas.
BACKGROUND
[0003] Stents are well known to those skilled in the biomedical
arts. In particular, stents are commonly used in cardiovascular
applications. Stents have gained increasing acceptance,
particularly when used in conjunction with minimally invasive
procedures such as angioplasty. Blockages of the coronary arteries
may result from various causes, including plaque build-up, and
stenosed or thrombosed vessel regions. The vessel regions thus
partially occluded can cause angina and, when totally occluded,
myocardial infarction, and even death. Minimally invasive
procedures such as balloon angioplasty have been used to dilate
such blocked vessel regions, thereby at least partially restoring
patent vessel lumens.
[0004] In a significant percentage of cases, a stenosed, then
dilated vessel region may narrow after treatment over a period
ranging from days to months. This re-narrowing or restenosis,
limits the efficacy of the angioplasty procedures, may require
further angioplasty, or can lead to myocardial infarction and even
death.
[0005] Cerebral blockages are typically caused by a thrombus. The
thrombus can form or lodge in a cerebral artery, preventing brain
regions downstream from receiving perfusing blood flow. The loss of
oxygen can rapidly cause brain death in the affected brain regions
if the blockage is not soon treated. The cerebral arteries are
generally smaller and more tortuous than the corresponding coronary
arteries. The required timing and difficult vessel characteristics
make reaching and treating the thrombus to prevent brain cell death
a most difficult task. The narrow cerebral vessels make placing
stents within the brain very difficult using current stents and
stent delivery systems. Microcatheters are currently used to infuse
drugs into cerebral blood vessels. The microcatheters are typically
not greater than about 4 Fr. (11/3 min.) in outer diameter,
currently being generally unsuitable for delivery of cerebral
stents.
[0006] Stents have been extensively utilized in an attempt to
prevent or limit restenosis. Stents are typically tubular devices
delivered to the stenosed and dilated site. The stents can be
expanded into place against the treated region walls, hopefully
preventing restenosis and further narrowing at the stented
location. Stents are often formed of metal, commonly stainless
steel or Nitinol. The stents can be open walled structures formed
from lattice-like cages, spiral wire structures, braided
structures, and helically wound and counterwound structures. Stents
can be self-expanding, designed to expand radially when distally
advanced from a restraining delivery catheter. Stents can also be
balloon-expandable. Balloon-expandable stents can be positioned and
then expanded from within using a stent delivery balloon and/or an
angioplasty balloon.
[0007] A typical stent delivery device includes a stent constrained
within an outer delivery sheath extending over the length of the
stent. When the device is advanced to the target site, the outer
sheath is proximally retracted and/or the stent is distally
advanced from within the sheath to the target site. The delivery
sheaths may work as intended, but do add bulk to the distal end of
the delivery device. In particular, the delivery sheath adds at
least one additional layer surrounding the stent. The delivery
sheaths are generally cylindrical in nature and extend over the
entire length of the stent. The stent can act to reinforce the
outer sheath. The delivery sheath and enclosed stent thus act to
form a rather rigid composite structure that is not as able to bend
and traverse the tortuous vessel regions often found in the human
body. The composite structure is thus not as flexible as either the
stent or sheath alone would be in traversing these passages.
[0008] The added bulk and profile or cross-sectional area of the
delivery device can thus act to restrict the use of such stents to
larger vessels. In particular, this may leave smaller vessels
unreachable and untreatable. Sites requiring treatment disposed on
the distal side of a tortuous curve may also be unreachable and
untreatable.
[0009] In use, some currently available stents and delivery systems
also have another limitation. For self-expanding stents, stent
placement is often imprecise. The placed or final stent length is
related to the final stent diameter that is related to the vessel
diameter. Within a vessel, the diameter is not always precisely
known, and can vary over the region to be stented. It may be nearly
impossible to predict the final stent length before the stent is
fully expanded in the vessel.
[0010] The difficulty in accurate stent placement can become an
issue in stenting a vessel ostium. It is often desirable to place a
stent precisely at the ostium of a vessel, especially in coronary
and renal vessels. If the stent is positioned too proximal, the
stent extends into the trunk line, and can cause flow disturbance.
If the stent is positioned too distal, the disease at the ostium is
not treated. Self-expanding stent delivery systems typically deploy
the stent from distal to proximal, with the distal stent end being
advanced distal-most. In particular, a self-expanding stent may be
advanced while disposed within a delivery sheath. When the sheath
distal end is in position, the sheath can be retracted, allowing
the accurately placed stent distal end to expand first. The
proximal end of the stent can vary depending on the vessel
diameter. In order to accurately place the stent proximal end, the
treating physician thus needs to guess at the position to start
stent deployment based on the assumed final stent length, so that
the proximal end of the stent ends up at the precise ostial
location desired.
[0011] What would be desirable are devices and methods for
delivering stents to target vessel regions that do not require the
added bulk of an external restraint or capture sleeve over the
stem. Applicants believe that devices and methods not absolutely
requiring a delivery sheath over the stent would allow smaller,
more tortuous, and more distal vessels to be effectively
treated.
SUMMARY
[0012] The present inventions include devices and methods for
delivering stents to target vessel regions within the body. Methods
and devices for delivering everted stents are preferred and
disclosed. One stent delivery assembly includes a delivery tube
having a stent slidably disposed over the delivery tube distal
region, and having the stent distal region everted over the
delivery tube distal end, such that the stent distal end is tucked
inside of the delivery tube distal end lumen. An elongate release
member having a distal element can be slidably disposed within the
delivery tube lumen. The release member distal element can be
dimensioned relative to the surrounding delivery tube distal end
inside diameter so as to form a tight fit between the release
member distal element and the surrounding delivery tube. The stent
distal region can be held by a friction or interference fit between
the release member distal element and surrounding delivery tube
walls. The stent is thus everted and reduced in outer diameter at
the leading, everted distal end.
[0013] In one delivery device, the elongate release member is
pulled from the proximal region, thereby proximally urging the
release member distal element free of the stent distal end captured
between the release member distal element and the surrounding
delivery tube distal end. In such embodiments, the release member
function may be served by an elongate string or wire having
significant strength mainly in tension rather than compression. In
another embodiment of the inventions, the elongate release member
function is served by a shaft having sufficient strength in
compression to distally urge the release member distal element by
manipulating the release element proximal region, forcing the
distal element from the surrounding delivery tube distal end,
thereby freeing and unconstraining the stent distal region. In some
embodiments, the delivery tube functionality is served by a
delivery shaft having only the distal region being tubular in
nature. In one such embodiment, the delivery shaft has a distal
hoop or annular ring for surrounding and capturing the everted
stent distal region within.
[0014] In use, the stent can be everted over the delivery tube or
shaft, with the stent distal end everted and captured by the
elongate release member. The everted stent, delivery shaft or tube,
and release member can be advanced distally to a target vessel
region to be stented. Once at the target region location, the
everted and constrained stent may be freed of the delivery shaft or
tube by the release member. The release member may be retracted
proximally in some embodiments, and advanced distally in other
embodiments, as previously discussed, to release the everted stent.
Once released, the stent is free to expand radially and approach
the surrounding vessel walls or blockage.
[0015] Self-expanding stents can be used in some embodiments of the
inventions. The stents are preferably biased to radially expand
when freed of the constraints of the delivery tube and release
member. In other embodiments, balloon expandable stents are used,
which can be expanded using inflatable balloon catheters or other
stent delivery devices.
[0016] Some methods according to the present inventions can utilize
a guide wire to facilitate advancement of a guide catheter or
microcatheter to a location near the vessel region to be stented.
The guide wire can be retracted, and the carried everted stent
advanced by the release member and guide tube together through the
guide catheter or microcatheter to the target region. In one
method, the everted stent carried by the delivery tube and release
member are advanced distally from the guide catheter to cross the
target region, for example, a blood vessel stenosis. In another
method, the microcatheter together with the everted stent carried
by the delivery tube and release member are advanced through the
stenosis or other blockage, followed by proximally retracting the
microcatheter, leaving the everted stent to expand against the
target region vessel or blockage walls. Once the everted stent is
in location, the release member can be activated by advancing or
retracting the member to free the everted stent.
[0017] Once unconstrained, the stent, for example, a self-expanding
stent, may expand to approach the vessel walls or the blockage. In
some embodiments, the release member may be advanced distally
through the previously placed stent lumen to guarantee a minimal
lumen through the stent and/or to act as a guide member for other
devices to be passed through the now stented region. In one method,
the delivery tube is advanced through the now stented region, which
can act to farther dilate the stent. In another method, the guide
catheter or microcatheter can also be advanced through the now
stented region, which can act to further dilate the stent. Thus, a
succession of ever increasing diameter devices may be advanced
through the stent after stent deployment in some methods. In
another method, a balloon catheter is advanced through the now
stented region followed by inflation of the balloon and concomitant
dilation of the stent.
[0018] In another use of the present inventions, an everted porous
stent carried by a delivery tube can be distally advanced through a
thrombosed blood vessel region. A wire mesh or braided stent may be
used. The everted stent can be released from the delivery tube to
expand against the thrombus. The delivered stent can thus act to
stabilize the thrombus. After stenting, the thrombus can be treated
by infusing thrombolytic agents near the thrombus, through the
walls of the porous stent. The stent can thus act to stabilize the
thrombus, preventing large pieces from breaking off and being
carried downstream during the thrombolysis.
[0019] Some embodiments of the present inventions have distally
tapered delivery tubes having very small distal end profiles. In
these embodiments, the release member distal element may be very
small in profile as well. The limit of the distal profile in such
devices may approach the lower size limit in gathering, everting,
and compressing the distal region of the stent to be delivered. In
these and other embodiments, the leading edge of the stent delivery
device can be very benign and atraumatic due to the everted stent
forming the distal-most leading edge of the device. Many
embodiments of the device thus eliminate the absolute need for a
delivery sheath or tube disposed about the stent, thereby
eliminating one set of tube profiles from the device, making the
distal region more flexible, smaller in profile, and able to reach
even more distal and smaller diameter vessels which will benefit
from treatment.
BRIEF DESCRIPTION OF THE DRAWINGS
[0020] FIG. 1 is a fragmentary, longitudinal, cross-sectional view
of a stent delivery assembly including a stent captured between the
distal ends of an elongate release member and the surrounding stent
delivery tube shown prior to evening the stent proximally over the
delivery tube;
[0021] FIG. 2 is a fragmentary, longitudinal, cross-sectional view
of the stent delivery assembly of FIG. 1 after the stent has been
everted and the device disposed within a guide catheter or
microcatheter;
[0022] FIG. 3 is a fragmentary, longitudinal, cross-sectional view
of the stent delivery assembly of FIG. 2 after the microcatheter
has been advanced proximal of a blockage and the captured, everted
stent carried further distally by the release member and delivery
tube;
[0023] FIG. 4 is a fragmentary, longitudinal, cross-sectional view
of the assembly of FIG. 3 after the stent has been released and
expanded within the target vessel region;
[0024] FIG. 5A is a fragmentary, longitudinal, cross-sectional view
of an alternate embodiment of the inventions where the delivery
tube is a delivery shaft having a distal tube or ring;
[0025] FIG. 5B is a wafer view taken through 5B of FIG. 5A,
illustrating the fit between the release member distal end, everted
stent, and delivery shaft distal end; and
[0026] FIG. 5C is a fragmentary, longitudinal, cross-sectional view
of another embodiment of the inventions, where the delivery tube
has a tubular distal region and coupled to a proximal shaft,
present technology.
DETAILED DESCRIPTION
[0027] The following detailed description should be read with
reference to the drawings, in which like elements in different
drawings are numbered identically. The drawings, which are not
necessarily to scale, depict selected embodiments and are not
intended to limit the scope of the inventions. Several forms of
inventions have been shown and described, and other forms will now
be apparent to those skilled in art. It will be understood that
embodiments shown in drawings and described above are merely for
illustrative purposes, and are not intended to limit scope of the
inventions as defined in the claims that follow.
[0028] FIG. 1 illustrates a stent delivery assembly including a
stent delivery device 20, a stent 26, a delivery shaft or tube 22,
and an elongate release member 24. Release member 24 can be used to
releasably secure or couple stent 26 to delivery shaft or tube 22.
Stent 26 is illustrated in a configuration prior to being everted
and proximally disposed about delivery tube 22. Delivery tube 22
may be seen to have a distal region 30, a distal end 28, an
intermediate region 32, a tube wall 38, a tube wall inner surface
36, and a lumen 34 therethrough. Release member 24 may be seen to
have a distal region 40 and a distal end 42 having a distal element
43. In the embodiment illustrated in FIG. 1, release member distal
end 42 is dimensioned so as to form an interference fit between
stent 26 and delivery tube wall inner surface 36. Delivery tube
wall 38 may be seen to be slightly distended in the area of release
member distal end 42. Stent 26, described with reference to the
everted state, has generally a distal region 46, a distal end 47,
an intermediate region 44, a proximal region 48, a proximal end 50,
and a lumen 52 therethrough.
[0029] Release member 24 may be seen, at distal end 42, to have an
outside diameter D1 which closely approximates the inside diameter
of delivery tube 22 in the distal region. Stent 26 may be seen
gripped between release member distal end 42 and delivery tube 22.
Stent 26, in some embodiments, may be biased to expand radially
when unconstrained. As illustrated in FIG. 1, stent proximal end 50
has an unconstrained diameter D2 that is substantially larger than
the constrained diameter D1. Self-expanding stents are well known
to those skilled in the art. Such self-expanding stents may be
formed, for example, from Nitinol, which can be heat set to assume
a desired shape when unconstrained. Stent 26 in FIG. 1 is
illustrated in an intermediate step during assembly. Stent proximal
end 50 may be everted and pulled proximally as a sleeve over
delivery tube 22. Other methods of assembly are possible. In
preferable methods, stent 26 may be heat set in an uneverted shape
and disposed as a sleeve over delivery tube distal region 30 in the
uneverted state. Stent distal region 46 may then be everted and
tucked within delivery tube distal end 28. Release member 24 may
then have its proximal end threaded through stent lumen 52 and
delivery tube lumen 34 until release member distal end 42 has been
proximally retracted within delivery tube distal region 28, firmly
capturing stent distal region 46 between the elongate member distal
end 42 and the delivery tube distal region 28.
[0030] FIG. 2 illustrates stent delivery device 20 further included
within a more comprehensive stent delivery assembly 60. Stent
delivery assembly 60 includes generally a guide catheter or
microcatheter 62 having a distal region 64, an intermediate region
69, a proximal region 72, and a distal end 66 having a lumen 68
therethrough. Release member 24 can have an optional collar 51
disposed about the release member distal region and dimensioned to
slidably fit within delivery tube 22. FIG. 2 further illustrates
release member 24 having a proximal region 25 coupled to an
optional larger diameter proximal end 27 dimensioned so as to form
an axially slidable seal between release member proximal end 27 and
the surrounding delivery tube proximal region 33. FIG. 2 also
illustrates optional annular seal member 29 forming a larger
diameter proximal region 33 for the delivery tube 22. Annular
element 29 may be seen to form a slidable seal between delivery
tube 22 and the surrounding guide catheter or microcatheter 62.
FIG. 2 also illustrates that stent 26 can expand outward radially
while within guide catheter 62. In particular, stent intermediate
region 44, proximal region 48, and proximal end 50 may be seen to
have expanded radially to the extent permitted by the surrounding
guide catheter 62. The dimensions illustrated for the proximal
region of stent delivery assembly 62 and FIG. 2 may vary depending
on the embodiment and the intended use. FIG. 2 illustrates only
one, non-limiting example of the inventions.
[0031] Microcatheters are well known devices, commonly used to
deliver drugs to cerebral arteries. "Microcatheters", as the term
is used herein, is defined to be a tubular catheter having an
outside diameter less than about 5 Fr. ( 12/3 mm,). Microcatheters
used with the present inventions preferably have an outside
diameter between about 1.5 Fr. (1/2 mm.) and 4 Fr. ( 11/3 mm),
inclusive. Microcatheters preferably have a floppy distal region
and tip, the distal region being more pliable and softer than the
intermediate and proximal microcatheter regions.
[0032] FIG. 3 illustrates one use of assembly 60 in a body conduit
or vessel 82 having a target region 80 at least partially occluded
by a blockage 84. Blockage 84 can at least partially block vessel
82, thereby reducing the effective size of vessel lumen 86.
Blockage 84 represents any of a number of blockages, including, but
not limited to plaque, thrombus, and a stenosed vessel region
generally.
[0033] In one method according to the present inventions, a
guidewire is advanced distally through the vessel until the
guidewire distal tip is across or proximally near vessel target
region 80. Guide catheter or microcatheter 62 can then be advanced
over the placed guidewire until microcatheter distal end 66 is
disposed proximal of blockage 84. In some methods, the guidewire is
now retracted proximally from microcatheter 62.
[0034] With microcatheter 62 in place, stent delivery device 20 may
be advanced through microcatheter lumen 68 to a position within
microcatheter 60 proximal of vessel target region 80. As may be
seen from inspection of FIG. 3, stent 26 is everted over the distal
end of delivery tube 22 and releasably secured to delivery tube 22
with elongate release member distal end 42. In the embodiment
illustrated, stent 26 is a self-expanding stent, with proximal end
50 having a larger outside diameter than constrained distal end
47.
[0035] With release member 24, delivery tube 22, and everted stent
26 in position, the release member, the delivery tube, and the
captured, constrained and everted stent 26 may be distally advanced
across the target site 80 having blockage 84. In some methods, the
advancing of release member, delivery tube, and everted stent is
accomplished while leaving guide catheter or microcatheter 62
positioned proximal of the vessel target site. In other methods,
guide catheter or microcatheter 62 is advanced across target vessel
region 80. In one method, microcatheter 62, everted stent 26,
delivery tube 22, and release member 24 are all advanced together
across target region 80. In this method, after microcatheter 62 and
constrained, everted stent 26 are across target vessel region 80,
microcatheter 62 can be proximally retracted, exposing the
stent.
[0036] As may be seen from inspection of FIG. 3, stent 26 is still
releasably secured to delivery tube 22 and may be further advanced
distally. In some uses of the inventions, a microcatheter such as
microcatheter 62 may be used to advance the releasably secured
stent and delivery tube only so far as the microcatheter can reach,
followed by the distal exit of the everted stent from the
microcatheter to attain even greater distal reach for the stent.
FIG. 3 also illustrates that stent 26 can be axially elongated as
the stent is pulled through narrow passages, which can reduce the
stent profile while the stent is being pulled.
[0037] Once everted stent 26 is at the desired location, the stent
can be released from delivery tube 22. In one example of the
inventions, release member 24 is urged proximally, thereby pulling
the release member distal end proximally until release member
distal end 42 is disposed proximally of everted stent distal end
47. Stent 26 may then expand further radially to embrace the
surrounding vessel target region 80. In another example of the
inventions, elongate release member 24 can be distally urged,
thereby forcing release member distal end 42 distally from delivery
tube 22, thereby releasing stent 26 from delivery tube 22. In
embodiments having optional collar 51, the collar can be used to
help push out the stent after release. Both distal and proximal
movement of release member 24 can be accomplished by manipulating
the proximally accessible portion of the release member. Stent 26
is then free to radially expand and retain its previous,
non-everted shape.
[0038] It may be seen from inspection of FIG. 3 that everted stent
26 has a smaller distal profile than proximal profile, allowing
easier entry into narrow target sites. In some embodiments of the
inventions, delivery tube 22 has a tapered distal tip, such that
the profile of the distal end of delivery tube 22 is smaller than
the profile of delivery tube 22 in an intermediate or proximal
location. FIG. 3 also illustrates that the everted distal region 46
of stent 26 forms a rather atraumatic tip, relative to many other
distal delivery devices and, in most embodiments, more benign than
the delivery tube distal end 28. Due in part to the self-expanding
nature of the stent illustrated in FIG. 3, distally urging the half
released, half secured stent forms a proximally widening shape that
can act to initially penetrate, then dilate a blocked vessel
region, prior to totally releasing the stent.
[0039] The distance between release member 24 and delivery tube 22
is indicated at D3 in FIG. 3. In some embodiments, the proximal and
intermediate regions of delivery tube 22 have a very tight fit
between release member 24 and delivery tube 22. A close tolerance
between the release member and the delivery tube can provide
columnar support for advancing release member 24. Such close
tolerance can also provide strength and stability when the elongate
release member 24 is retracted proximally to release stent 26, in
embodiments calling for such retraction.
[0040] FIG. 4 illustrates vessel target region 80 after stent 26
has been expanded to create and stabilize an expanded or dilated
flow channel 87 through vessel 82. Stent proximal region 48 and
distal region 46 may be seen to have expanded radially against
blockage 84. Stent 26 is preferably radially expanded outwardly
against the vessel walls and/or blockage once released by release
member 24. In one method, stent 26 is biased to radially expand
outwardly, once unconstrained. Some self-expanding stents useful
with the present inventions are formed of Nitinol. Stents may be
heat-set to radially expand and assume the heat-set diameter once
released in some methods.
[0041] In one method according to the inventions, after stent 26
has been allowed to expand radially, this process may be assisted
using parts of the device previously described. In embodiments
where the release rod has sufficient strength in compression to be
pushed, release member 24 may be advanced distally through deployed
stent 26 to ensure that an initial clear flow passage exists
through stent 26. Elongate release member 24 may be followed by
distally advancing delivery tube 22 through deployed stent 26. In
other methods, guide catheter or microcatheter 62 may be advanced
through deployed stent 26, to further widen the already stented
passage. These methods may also be employed to assist with eversion
of the distal end of the released but incompletely deployed stent.
In some methods, the delivery tube and release member may be
retracted proximally, and an inflatable balloon catheter advanced
to the now stented vessel site to further dilate the deployed stent
by inflating the inflatable balloon disposed in the balloon
catheter distal region.
[0042] FIG. 3 illustrates only one embodiment of the inventions,
which is not necessarily drawn to scale. In particular, in some
embodiments, the distal region of delivery tube 22 can be
significantly smaller in profile. In one embodiment, release member
24 has distal end 42 being substantially smaller in profile than
that illustrated in FIG. 3. In one embodiment, distal end 42 is
tapered distally or proximally to facilitate the frictional fit
between the stent and the delivery catheter. The inside of the
delivery catheter distal region and/or outside of the release
member distal end 42 can be coated with a compressible, tacky,
flowable, or high friction material to augment the security of
reversible stent engagement. In one device, release member distal
end 42 is only slightly larger in profile than the intermediate
portion of release member 24. In one embodiment, release member 24
has strength substantially only in tension rather than compression,
and acts as a string. This string or wire can be very small in
profile, and can be coupled to a very small release member distal
element. In one embodiment, elongate release member 24 is a fine
gauge wire, metallic or polymeric, coupled to a small distal plug.
Delivery tube distal end 28 may also be much smaller and
significantly distally tapered relative to that illustrated in FIG.
3. Delivery tube distal end 28 may also be reinforced against
diametric enlargement by incorporation of a strong circular loop or
band within or outside of the wall of the delivery tube distal end.
Preferably the loop or band is metallic and more preferably
radiopaque so as to facilitate visualization under fluoroscopy.
[0043] Inspection of FIG. 3 indicates that the lower limit on the
transverse cross-sectional size or profile of the stent delivery
assembly may be limited by the profile of the everted stent 26. In
one embodiment of the inventions, elongate release member 24 is
effectively a thin wire or string terminating distally in a plug or
ball shape only slightly larger in profile than the wire or string.
Delivery tube 22 may be, significantly distally tapered such that
the inside diameter of the delivery tube distal end approaches the
outer diameter of the release member distal end or plug 42. The
stent may thus be everted and the stent distal region tightly
bunched or gathered together between the small distal ball or plug
and the surrounding, tapered, distal end of the delivery tube.
While the release member and delivery tube occupy space, it may be
seen that the absolute lower limit of the cross-sectional profile
in some embodiments may be ultimately bounded by the lower size
limit in releasably compressing the stent distal end.
[0044] FIG. 5A illustrates another embodiment of the inventions.
The stent delivery assembly 100 illustrated in FIG. 5A can be
similar to that of assembly 20 as illustrated in FIGS. 1 and 2.
Delivery assembly 100 may be seen to have an everted stent 26 and
an elongate release member 24 as previously discussed. Assembly 100
has a delivery shaft 122 rather than a delivery tube. Delivery
shaft 122 has an intermediate region 132 extending to a distal
region 124. Distal region 124 includes support struts 128 extending
distally and radially outward to support a short tube section or
annular ring 126. In some embodiments, annular tube or ring 126 may
be significantly longer than that illustrated in FIG. 5A, which is
not necessarily to scale. The distal region of delivery shaft 122
may thus form a delivery tube in the many respects previously
discussed. Stent 26 may be seen to be everted over distal annular
ring or hoop 126 and held in place by a tight, interference fit
between release member distal element 43 and annular ring 126. As
may be seen from inspection of FIG. 5A, everted stent 26 may be
released from the assembly 100 by proximally retracting release
member 24 or distally extending release member 24, depending on the
embodiment and the properties of the release member shaft forming
release member 24. FIG. 5B illustrates a transverse cross-sectional
view of the assembly 100 of FIG. 5A, showing release end element 43
disposed within one layer of stent 26 which is in turn disposed
within annular ring 126 which has a second layer of stent 26
disposed to the outside.
[0045] FIG. 5C illustrates another stent delivery assembly 160,
somewhat similar to that of delivery assembly 100 of FIG. 5A and
having the same reference numerals for similar elements. Assembly
160 includes elongate release member 24 and stent 26 as previously
discussed. The delivery device includes a distal tube 166 coupled
to a proximal elongate member or shaft 162. Tube 166 includes a
proximal end 174, a distal region 170, a distal end 172, and a
lumen 168 extending through the tube. Proximal shaft 162 can be
coupled to tube 160 at a shaft distal region 164. Proximal shaft
162 can extend distally along or within tube 166 in some
embodiments. Tube 166 may be slit to accommodate proximal shaft
162.
[0046] Stents that may be used with the present inventions include
self-expanding and balloon expandable stents, well known to those
in the cardiovascular arts. Stents may be formed from many of the
well known stent materials, including Nitinol, stainless steel, and
polymers. The stents may be braided, knit, meshed, formed of
non-woven wires, helically wound and helically counterwound. Stents
according to the present inventions are preferably porous, wire,
braided stems, with various embodiments having an average pore or
inter-wire opening size of at least about 20 microns in one
embodiment, and at least 50 microns in another embodiment. In a
preferred embodiment the stent ends are coated with flexible
adherent material to prevent unraveling of, for example, braided
stents. Alternatively, the stent strands can be welded or otherwise
fastened to one another to prevent unraveling during eversion.
[0047] In one use of the inventions, the everted stent may be used
to stabilize a blockage such as a thrombus, while providing a
perfusing path through the dilated thrombus. In another use, the
stent may be positioned across a stenosed blood vessel region, and
the region treated with a restenosis inhibiting agent. The
restenosis inhibiting agent can be infused through the porous stent
wall or reside on the stent itself and release into the vessel
wall. FIGS. 3 and 4 may be used to visualize blockage 84 being
formed primarily of thrombus, with stent 26 being put in place to
primarily stabilize the thrombus and to provide oxygenating blood
flow to downstream brain regions, preventing brain cell death.
Small distal profile catheters as previously discussed and as
illustrated in FIG. 3 may thus be used to advance an everted stent
across a thrombus and deploy the stent. The stent, which can be
either self-expanding or expandable from within using a stent
placement device, can then expand against the vessel walls and/or
blockage. In some methods, an infusion catheter is advanced to
within vessel site 80, and thrombolytic agents infused through the
porous stent wall. Various therapeutic agents may be applied in
this way. A non-limiting list of such therapeutic agents includes
thrombolytic agents, anticoagulants, anti-platelet agents, and
tissue plasminogen activator. In a similar way, stents according to
the present inventions can be used to treat an area stenosed
because of arteriosclerosis.
[0048] The present inventions can be used to accurately position
the stent proximal end. The stent proximal end may be positioned
accurately relative to a vessel ostium. The stent can be positioned
near the proximal end of a stenosis located near or at an ostium.
The everted stent can be advanced as previously discussed, until
the proximal end is positioned at the desired location. The stent
proximal end can be allowed to radially expand against the vessel
walls. In some methods, the stent can be advanced further distally
until the expanded proximal end is at the desired position. The
stent placement may be followed using fluoroscopy. This desired
position may be exactly at the ostium beginning, slightly within
the ostium, or extending slightly from the ostium. The stent distal
region can be released and allowed to expand. In this way, the
stent proximal end can be positioned accurately relative to the
ostium.
[0049] In one embodiment of the inventions, the elongate release
member has a length of between about 100 cm, and 200 cm. In one
embodiment, the outer diameter of the release member distal element
is less than 2 mm. In various embodiments, the release member may
be formed from stainless steel, Nitinol, polyimide, reinforced
polymer, or PEEK and the like.
[0050] The delivery tube or shaft in some embodiments has a length
of between about 75 cm, and 175 cm. The delivery tube can have an
outside diameter of between about 6 Fr. and 1 Fr. In various
embodiments of the inventions, the distal region of the delivery
tube may be distally tapered. In some embodiments, the
cross-sectional outer diameter of the delivery tube distal end is
less than about 6 Fr. Delivery tubes can be made from flexible
polymers such as PEBAX, nylon, polyester, polyurethane,
polyethylene, FEP, Teflon, silicone, and the like, with or without
reinforcement by metallic or polymeric elements. Microcatheters are
well known to those skilled in the art and any suitably sized guide
catheter or microcatheter may be used in combination with the
present inventions, preferably about 3 Fr. or 4 Fr. in outer
diameter. Some exemplary sized catheters that can be used with the
present inventions are between about 75 cm. and 175 cm. in length.
Guide or microcatheters useful in conjunction with the present
inventions may be formed from Nylon, PEBAX, polyurethane, and the
like. Guide catheters can be reinforced with metallic braids, with
microcatheters preferably having very flexible distal end regions.
The catheters can have a distal outer diameter of less than about 8
Fr, for guides and 4 Fr, for microcatheters.
* * * * *